Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-28 @ 12:19 AM
Study NCT ID:
NCT00826150
Status:
COMPLETED
Last Update Posted:
2019-06-13
First Post:
2009-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer
Sponsor:
Anchiano Therapeutics Israel Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-18
First Submit QC Date:
None
Study First Post Date:
2009-01-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-22
Results First Submit QC Date:
None
Results First Post Date:
2019-06-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-21
Last Update Post Date:
2019-06-13
Last Update Post Date Type:
ACTUAL